• 免費註冊
  • 加入官方line@
  • 加入FB粉絲團

台股 » 個股 » 太景*-KY » 籌碼相關 » 券商分點績效 » 券商分點個股進出

太景*-KY

(4157)
可現股當沖
  • 股價
    10.80
  • 漲跌
    ▼0.05
  • 漲幅
    -0.46%
  • 成交量
    438張
  • 產業
    上櫃 生技醫療類股▲0.61%

  • 265人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
太景*-KY (4157)籌碼相關－國票-九鼎 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效，來找出真正獲利的贏家所在券商分點，進而追蹤此贏家所操作的股票與軌跡。

股票投資新手教室：一秒知道是否上對大戶列車

國票-九鼎 券商分點個股進出

國票-九鼎 券商分點全部個股操作績效/獲利分析

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/132010.751010.8510.70101,2150.82%
2025/01/10211.351011.1311.35-81,185-0.68%
2025/01/0900.001011.4011.25-101,156-0.86%
2025/01/071011.0500.0011.05101,1220.89%
2024/12/2700.00611.5511.50-61,133-0.53%
2024/12/26311.9000.0012.0031,1560.26%
2024/12/19611.060.110.9510.905.91,1110.53%
2024/12/16111.4500.0011.2011,1250.09%
2024/12/13011.6000.0011.4501,1240.00%
2024/12/12012.0000.0011.8001,1080.00%
2024/12/111.111.8500.0011.851.11,1060.10%
2024/12/0900.00311.8511.85-31,129-0.27%
2024/12/06111.9500.0012.0011,1220.09%
2024/11/26212.1300.0012.3021,1330.18%
2024/11/21112.5000.0012.6019260.11%
2024/11/1800.00212.2012.20-2965-0.21%
2024/11/1300.00113.1513.10-1879-0.11%
2024/11/0400.001013.9513.95-10953-1.05%
2024/10/0900.00114.4014.40-11,173-0.09%
2024/10/0100.00214.9515.10-21,323-0.15%
2024/09/3013.314.9000.0014.9513.31,3111.02%
2024/09/180.114.6000.0014.550.11,3980.01%
2024/09/1100.00114.2514.20-11,436-0.07%
2024/09/1000.00214.0514.50-21,458-0.14%
2024/09/0400.001014.0013.95-101,629-0.61%
2024/09/020.214.5500.0014.500.21,7410.01%
2024/08/30414.55414.6014.5001,7590.00%
2024/08/1600.00314.6014.55-31,812-0.17%
2024/08/1400.0010014.3514.55-1001,856-5.39%
2024/08/09214.3500.0014.3021,9140.10%
2024/08/0500.002013.5013.45-201,901-1.05%
2024/07/23114.2500.0014.2011,9560.05%
2024/07/22214.231014.3014.15-81,976-0.40%
2024/07/16214.5500.0014.5022,2490.09%
2024/07/1500.00114.6014.55-12,664-0.04%
2024/07/11214.4500.0014.5022,7980.07%
2024/07/10114.4500.0014.4512,8290.04%
2024/07/02115.10115.0515.0502,7010.00%
2024/07/012115.1500.0015.10212,7120.77%
2024/06/2800.00115.2015.15-12,704-0.04%
2024/06/2710.715.3500.0015.2510.72,7260.39%
2024/06/2500.002315.0415.05-232,714-0.85%
2024/06/2400.00115.2015.10-12,745-0.04%
2024/06/2100.003015.0515.15-302,769-1.08%
2024/06/1700.00115.2015.35-12,814-0.04%
2024/06/14515.0500.0015.0552,7920.18%
2024/06/131015.1500.0015.00102,7730.36%
2024/06/113115.65715.7915.55242,7060.89%
2024/06/07115.7000.0015.4012,6490.04%
2024/06/04415.20215.3015.2522,5830.08%
2024/05/30115.2000.0015.3512,6210.04%
2024/05/29115.0500.0015.1012,6170.04%
2024/05/282015.0500.0015.05202,6160.76%
2024/05/27515.0500.0015.0052,6120.19%
2024/05/23115.3500.0015.2012,6160.04%
2024/05/21215.6300.0015.6022,6190.08%
2024/05/20215.5500.0015.6522,6060.08%
2024/05/13515.2500.0015.0552,5660.19%
2024/05/091015.3000.0015.35102,5400.39%
2024/04/30115.60215.4015.35-12,429-0.04%
2024/04/292115.40215.3515.65192,4070.79%
2024/04/2500.00115.4515.50-12,345-0.04%
2024/04/24115.5500.0015.4512,3260.04%
2024/04/232715.52115.5015.50262,2951.13%
2024/04/227516.36115.7515.60742,2473.29%
2024/04/193717.031816.9816.45192,0410.93%
2024/04/18415.751215.7515.75-81,621-0.49%
2024/04/161114.4000.0014.25111,4490.76%
2024/04/0300.00015.2515.0501,4360.00%
2024/03/27315.505415.4115.45-511,324-3.85%
2024/03/2600.00215.4515.35-21,298-0.15%
2024/03/255415.441514.9515.40391,2733.06%
2024/03/2200.00114.8014.90-11,236-0.08%
2024/03/211514.50114.6014.70141,2441.12%
2024/03/20114.4000.0014.3511,2380.08%
2024/03/1300.00214.7014.50-21,259-0.16%
2024/03/1200.00115.0014.90-11,267-0.08%
2024/03/07114.4000.0014.7511,4920.07%
2024/03/0400.007914.9514.85-791,630-4.84%
2024/02/2900.00215.1515.10-21,896-0.11%
2024/02/22115.4500.0015.2511,8640.05%
2024/02/19115.6000.0015.5011,8350.05%
2024/02/16315.2500.0015.4031,8030.17%
太景抗流感病毒新藥 正式向中國藥監局申請上市許可UDN聯合新聞網－2024/08/04
太景*-KY（4157）4日晚間公告，接獲合作夥伴健康元藥業集團通知，太景開發的抗流感病毒新藥Pixavir (TG-1......詳全文
太景*-KY流感抗病毒新藥三期臨床 提前完成收案750人Anue鉅亨－2024/01/08
...詳全文
太景新藥 取得俄國藥證UDN聯合新聞網－2022/08/29
太景*-KY （4157）昨（28）日代子公司太景生技公告，抗生素新藥奈諾沙星靜脈輸液（500 mg/250 ml）已獲......詳全文
太景*-KY 相關文章